1996
DOI: 10.1097/00003072-199606000-00017
|View full text |Cite
|
Sign up to set email alerts
|

Imaging of a Mediastinal Thymic Carcinoid Tumor With Radiolabeled Somatostatin Analogue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

1999
1999
2012
2012

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 2 publications
0
10
0
Order By: Relevance
“…The 123 I MIBG scan was also performed in order to detect neuroendocrine tissues, but its sensitivity is unknown in this tumor. We note that SRS detects primary and metastatic thymic tumors, including TNET [7,8,14]. …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The 123 I MIBG scan was also performed in order to detect neuroendocrine tissues, but its sensitivity is unknown in this tumor. We note that SRS detects primary and metastatic thymic tumors, including TNET [7,8,14]. …”
Section: Discussionmentioning
confidence: 99%
“…To our best knowledge, 28 cases of TNET in which SRS was performed have been reported to date in the literature (table 1) [5,7-10,15-18], and only one study in abstract form has reported a patient with TNET with MEN 1 having a "false" negative SRS [17]. Tiffet et al [19] in a study of 12 neuroendocrine tumors arising in the thymus, found that none of the 12 tumors stained positively for somatostatin receptors, while Boix et al in a case of a 33 year-old-woman with MEN 1 described positive somatostatin receptor staining by immunohistochemistry [20].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, a high in vivo uptake of 111 In-DTPA-d-Phe 1 -octreotide was reported in patients bearing thymic neoplasms (17,18) and a successful treatment with octreotide was reported in one patient with thymoma (19). Recently, a high in vivo uptake of 111 In-DTPA-d-Phe 1 -octreotide was reported in patients bearing thymic neoplasms (17,18) and a successful treatment with octreotide was reported in one patient with thymoma (19).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, SS-R have been demonstrated in vitro in various lymphatic tissues (16). Recently, a high in vivo uptake of 111 In-DTPA-d-Phe 1 -octreotide was shown in patients bearing thymomas and thymic carcinoids (17,18), and a successful treatment with octreotide was reported in one patient with thymoma (19). The presence of SS and SS-R in the thymus suggests their involvement in controlling the immuno-and/or neuroendocrine functions in this organ.…”
mentioning
confidence: 99%